Did you know pathogenic bacteria can target inhibitory receptors to evade phagocyte responses? A recent study from our lab and that of Alex McCarthy (Imperial College) shows how Group B strep hijacks neutrophil LILRB3 to evade antibody-mediated immunity. 👇nature.com/articles/s41467-0…
Brian V Geisbrecht Lab retweeted
In a #TopRead from @bvglab at @KStateResearch, data show that Efb-C binding to C3b exerts additional inhibitory effects on the central complement components beyond blocking formation of the C3 proconvertase alone. Learn more: ow.ly/yzsN50Z19xU.
New work from our lab published in @J_Immunol!
In a study led by @HuiquanDuan, we found that conformation-dependent recruitment of FHR-2 to the complement component C3b leads to synergistic inhibition of the terminal pathway. Link below 👇
doi.org/10.1093/jimmun/vkaf3…
Congratulations to Ying Zhang on the recent defense of her dissertation research concerning bacterial evasion of antibody mediated immune responses.
Brian V Geisbrecht Lab retweeted
Registration now available online: 18th Int'l Conference on #ComplementTherapeutics aegeanconferences.org/src/Ap…
Many thanks to Jacob, Brewmaster of @aggievillebeer in #MHK for sharing his knowledge of the science behind beer making with @KStateBMB #Biochemistry and Society students this morning!
Brian V Geisbrecht Lab retweeted
Congratulations to all the trainee awardees! Great Work! Great Science! 17th Int’l Conference on #Complement Therapeutics.







